Literature DB >> 27607866

Gynecologic Outcomes After Hysteroscopic and Laparoscopic Sterilization Procedures.

Rebecca B Perkins1, Jake R Morgan, Temitope P Awosogba, Shaalini Ramanadhan, Michael K Paasche-Orlow.   

Abstract

OBJECTIVE: To compare rates of gynecologic morbidity after laparoscopic and hysteroscopic sterilization.
METHODS: This retrospective cohort study used a commercial claims administrative database, 2007-2013, to compare rates of pregnancy, menstrual dysfunction, pelvic pain, hysteroscopic surgery, and intra-abdominal gynecologic surgery after laparoscopic and hysteroscopic sterilization. Women with 12 or more continuous months of data before and after their index procedure were included. Pregnancy rates after laparoscopic and hysteroscopic sterilization were compared for the entire population of women who underwent hysteroscopic sterilization and the subset who had completed postprocedure hysterosalpingograms. Cox proportional hazard models were calculated controlling for age, comorbidities, U.S. geographic region, metropolitan statistical area designation, and insurance type.
RESULTS: A total of 42,391 women underwent laparoscopic and 27,724 underwent hysteroscopic sterilization. The pregnancy rate was higher after hysteroscopic than laparoscopic sterilization (adjusted hazard ratio [HR] 1.20, 95% confidence interval [CI] 1.09-1.33; 2.4% compared with 2.0% risk of pregnancy at 2 years). Only 66.1% (n=18,318) of women who underwent hysteroscopic sterilization received a hysterosalpingogram. This group had similar pregnancy rates as those who underwent laparoscopic sterilization (adjusted HR 0.90, 95% CI 0.80-1.02; 1.8% compared with 2.0% at 2 years). After undergoing hysteroscopic sterilization, more women were diagnosed with menstrual dysfunction (adjusted HR 1.23, 95% CI 1.20-1.27; 26.8% compared with 22.3% at 2 years), and more women underwent hysteroscopic surgeries (adjusted HR 2.05, 95% CI 1.96-2.14; 13.8% compared with 6.4% at 2 years), but fewer women were diagnosed with pelvic pain (adjusted HR 0.83, P<.001; 21.0% compared with 25.6% at 2 years) and fewer women underwent intra-abdominal gynecologic surgeries (adjusted HR 0.95, 95% CI 0.90-0.99; 7.7% compared with 8.1% at 2 years), including hysterectomy (adjusted HR 0.65, 95% CI 0.61-0.69; 10.9% compared with 14.3% at 5 years).
CONCLUSION: Hysteroscopic sterilization may be associated with a higher rate of pregnancy, more menstrual dysfunction, more hysteroscopic surgeries, less pelvic pain, and fewer intra-abdominal gynecologic surgeries than laparoscopic sterilization. Pregnancy rates appear to be similar for women who completed their postprocedure hysterosalpingogram, but only 66% of women did so.

Entities:  

Mesh:

Year:  2016        PMID: 27607866     DOI: 10.1097/AOG.0000000000001615

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Association of Hysteroscopic vs Laparoscopic Sterilization With Procedural, Gynecological, and Medical Outcomes.

Authors:  Kim Bouillon; Marion Bertrand; Georges Bader; Jean-Philippe Lucot; Rosemary Dray-Spira; Mahmoud Zureik
Journal:  JAMA       Date:  2018-01-23       Impact factor: 56.272

2.  Pelvic Pain and Apical Prolapse Surgery: A Population-Based Retrospective Cohort Study.

Authors:  Mostafa A Borahay; Burak Zeybek; Parin Patel; Yu-Li Lin; Yong-Fang Kuo; Gokhan S Kilic
Journal:  Female Pelvic Med Reconstr Surg       Date:  2020-11       Impact factor: 1.913

3. 

Authors:  Alberto López García-Franco; José Antonio Baeyens Fernández; Emilia Bailón Muñoz; M José Iglesias Piñeiro; Isabel Del Cura González; Amparo Ortega Del Moral; Jacinta Landa Goñi; Pablo Alonso Coello; Lorenzo Arribas Mir
Journal:  Aten Primaria       Date:  2018-05       Impact factor: 1.137

4.  Comparing options for females seeking permanent contraception in high resource countries: a systematic review.

Authors:  Rebecca Gormley; Brian Vickers; Brooke Cheng; Wendy V Norman
Journal:  Reprod Health       Date:  2021-07-20       Impact factor: 3.223

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.